about
Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditionsMeta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile NeutropeniaThe polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?Vascularized composite tissue allotransplantation--state of the artSafety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II studySeroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.Transmission of lymphocytic choriomeningitis virus by organ transplantation.Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies.Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review.Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy.Incidence and risk factors for herpes zoster following heart transplantation.Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosisCerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.Antifungal use in HIV infection.Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.A breath fungal secondary metabolite signature to diagnose invasive aspergillosisMolecular methods to improve diagnosis and identification of mucormycosisGordonia bronchialis bacteremia and pleural infection: case report and review of the literature.A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.Risk factors for invasive fungal disease in heart transplant recipients.Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritisDAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilationSerum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia.Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year ExperienceRespiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methodsInfections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumoniaUtility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis.Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature.Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature.Infectious complications associated with immunomodulating biologic agents.Infectious complications associated with immunomodulating biologic agents.Isavuconazole treatment of a patient with disseminated mucormycosis.
P50
Q24629910-CB18D64E-3ED3-4275-AFDB-6CF023B51E82Q26778187-5179DF23-E4F5-4E44-9931-67832C705948Q26853697-C42B0FFE-5534-4202-AA79-EFBE207A05F2Q26992026-7C7E0DD6-C47D-4C73-A722-D52C0E720833Q30353217-2842AEBD-D1B3-446A-AEE4-C88AA64678ABQ30394925-33DA33E0-8AF1-4580-9BF0-8C8C879B3E27Q33371315-6B15B36A-23ED-4A57-9157-9813566F1EC1Q33385831-D462FEA3-2261-499B-8FA1-EDE3007488F9Q33526435-7F9D8A46-A68A-4C49-9313-C646031126F4Q33598276-F91856BA-189E-403D-AB5E-52D10A092563Q33603683-6E1A3A6F-79EA-44EB-93B5-96BF42D455F2Q33637650-59C0B171-700A-400C-B3B0-8B7290A3B369Q33703554-12E0158D-D6C5-4A35-B7CA-BFF3F6D2EA75Q33726698-6292FC51-77F3-4D5B-943E-68103AEC69DCQ33769712-DDD4FC78-CD72-4D01-9639-BC1504C6E2D6Q33821247-F5642364-D16C-4EFC-8862-2F4A37F7F649Q34362427-3A829D62-B491-461B-B3F9-29C7FAA4ED28Q34519212-D61F4436-0C6D-467C-B59A-111E9893EFD1Q34539993-AFA4989E-9530-432A-B462-1C062C1AA530Q35029333-93F584D4-EF61-4F76-9987-0BE684AB638BQ35066797-AF54BF5F-4B02-4973-9679-32BF2DBFAEC8Q35066945-D2A112DF-4A44-4CD9-AA96-2C1188E843A3Q35081168-994C4BBD-D0E4-4516-A40F-85228F74BA09Q35202366-C9ED680A-96C1-4FF9-BB4D-D78430356954Q35240401-4CE66FFF-047B-4280-92D6-60C593FB58FDQ35655534-9F4549A2-0E3D-4389-B171-0ED73BBC0A0EQ35749971-F27B18EE-C05B-4906-A4A3-CC70853D281AQ35806943-443F415D-A7F7-4000-B36C-961B60C126D7Q35916585-41BEFAA6-304A-46EA-BDD3-7815CB36A50EQ36277119-890ABB05-BA76-4D08-92EC-B6CBA1FBCAB9Q36473993-FF618A5C-DC6D-4386-ADFC-AF4B892DBEC5Q36744771-503E45EA-6EB0-49F3-932E-C9C6A2234468Q37029566-FA7A35DD-4971-4C05-822E-E508F3E22869Q37249498-BE9EAE5B-6169-4DFA-91C5-DF9844131420Q37276889-481B3673-9CCE-4617-95DC-D0C38F4666EDQ37608657-D8139E68-1EFC-45F1-8150-882834B4E47BQ37679217-4D79087F-2BF9-498B-B1D5-7571BC66B157Q37751347-137AAFFF-620C-4A2F-9F64-A10692B1C940Q37828741-96C30657-8B80-476F-A994-49DA9CAB96CAQ38322367-0A5E336C-8661-49DE-85EF-E8618A706788
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francisco M. Marty
@ast
Francisco M. Marty
@en
Francisco M. Marty
@es
Francisco M. Marty
@nl
Francisco M. Marty
@sl
type
label
Francisco M. Marty
@ast
Francisco M. Marty
@en
Francisco M. Marty
@es
Francisco M. Marty
@nl
Francisco M. Marty
@sl
prefLabel
Francisco M. Marty
@ast
Francisco M. Marty
@en
Francisco M. Marty
@es
Francisco M. Marty
@nl
Francisco M. Marty
@sl
P106
P1153
7005666038
P21
P31
P3835
francisco-marty
P496
0000-0002-3708-8734